Directly targeting the endogenous opioid process: By blocking the ACKR3 receptor, conolidine lets the body's normal opioid peptides like endorphins, to work extra correctly. It is a classy way to offer superior ache relief using the system's intrinsic units.The very first asymmetric full synthesis of conolidine was made by Micalizio and coworkers